baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UC BON.CAP.CERT. 09/24 AMD/ DE000HD3TH50 /

22/05/2024 11:46:33	Chg.+0.060	Bid12:10:02	Ask12:10:02	Underlying	Strike price	Expiration date	Option type
221.660EUR	+0.03%	221.590 Bid Size: 200	221.640 Ask Size: 200	Advanced Micro Devic...	- USD	27/09/2024	Call

GlobeNewswire 21/05 AMD Instinct MI300X Accelerators Power Microsoft Azure OpenAI Service Workloads and New Azure ND MI3...

GlobeNewswire 21/05 AMD Expands EPYC CPU Portfolio to Bring New Levels of Performance and Value for Small and Medium Bus...

GlobeNewswire 21/05 Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroi...

GlobeNewswire 21/05 YieldMax™ Launches Option Income Strategy ETF on the VanEck® Gold Miners ETF (GDX®)

TeleTrader 20/05 Microsoft will 'soon welcome' AMD, Intel chips

GlobeNewswire 20/05 Broadcom Revolutionizes AI Networking Landscape with High-Performance 400G RoCE/RDMA Ethernet NICs

Newsfile Corp 16/05 FDA Grants AI-Powered Notal Vision Home OCT "SCANLY" De Novo Marketing Authorization

GlobeNewswire 15/05 Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Cor...

GlobeNewswire 14/05 AMD Announces Upcoming Events for the Financial Community

GlobeNewswire 14/05 Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facilit...

GlobeNewswire 14/05 Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 13/05 Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5...

GlobeNewswire 13/05 AMD Remains the Partner of Choice for World’s Fastest and Most Efficient High Performance Computing ...

GlobeNewswire 09/05 Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 09/05 Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlight...

GlobeNewswire 09/05 4DMT Reports First Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire 08/05 Alkeus Pharmaceuticals Announces Positive Interim Results Demonstrating No Signs of Disease Progress...

GlobeNewswire 08/05 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...

GlobeNewswire 08/05 AMD Receives IEEE 2024 Corporate Innovation Award for Leadership in Chiplet Design for High-Performa...

GlobeNewswire 08/05 Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results

GlobeNewswire 08/05 EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporat...

GlobeNewswire 07/05 Ocular Therapeutix™ Reports First Quarter 2024 Results

GlobeNewswire 07/05 Optiver Chooses AMD Enterprise Portfolio to Power its Data Center Modernization, Enabling New Era of...

GlobeNewswire 07/05 Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results

GlobeNewswire 07/05 Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

UC BON.CAP.CERT. 09/24 AMD/ DE000HD3TH50 /

If you wish to receive reply to your feedback, please provide your email address.